MICS + trabeculectomy a good match

Article

Microincision cataract surgery (MICS) combined with trabeculectomy provides a one-year intraocular pressure (IOP) control comparable to that found with trabeculectomy and separate temporal clear corneal phaco, according to the results of a study by Dr Bayer and colleagues from the Ankara School of Medicine, Turkey.

Microincision cataract surgery (MICS) combined with trabeculectomy provides a one-year intraocular pressure (IOP) control comparable to that found with trabeculectomy and separate temporal clear corneal phaco, according to the results of a study by Dr Bayer and colleagues from the Ankara School of Medicine, Turkey.

A total of 63 eyes with co-existing cataract and glaucoma were randomly assigned to receive mitomycin-C (MMC) trabeculectomy in the superior quadrant combined with phaco and foldable intraocular lens (IOL) implantation through a separate, temporal, clear corneal incision (2-site group) or MMC trabeculectomy in a superior quadrant combined with MICS followed by IOL implantation from the trabeculectomy incision.

Mean preoperative IOP was 28.1±7.1 mmHg and 27.7±6.5 mmHg in the 2-site and MICS groups, respectively. At six-months postoperatively, mean IOP was 14.9±4.3 and 14.3±3.8 mmHg, respectively (p=0.7) and at 12 months, 15.6±3.3 and 15.1±3.1 mmHg, respectively (p=0.5). Postoperative astigmatic change and complications were comparable between the groups.

Dr Bayer concluded that MICS with trabeculectomy and trabeculectomy with separate temporal clear corneal phaco provide comparable IOP control at one-year.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
Related Content
© 2025 MJH Life Sciences

All rights reserved.